FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of January, 2003
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Holding(s) in Company dated 14 January, 2003
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
| Celltech Group plc |
2. Name of shareholder having a major interest
| The Capital Group Companies, Inc. on behalf of its affiliates, including Capital International S.A., Capital International, Inc., Capital Guardian Trust Company and Capital International Limited |
3. Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18
| As in 2 above |
4. Name of the registered holder(s) and, if more than one holder, the number
of shares held by each of them
| Midland Bank plc 330,500 |
| Mellon Nominees (UK) Limited 218,200 |
| HSBC Bank plc 9,200 |
| State Street Bank & Trust Co. 35,000 |
| Nortrust Nominees 1,129,200 |
| Citibank London 123,500 |
| Bankers Trust 139,800 |
| Chase Nominees Limited 1,384,500 |
| Bank of New York Nominees 96,500 |
| State Street Nominees Limited 212,800 |
| Barclays Bank 70,000 |
| Bankers Trust 2,242,800 |
| Mellon Nominees (UK) Limited 63,500 |
| KAS UK 21,600 |
| Northern Trust AVFC 95,800 |
| Mellon Bank N.A. 230,300 |
| HSBC Bank plc 366,400 |
| Deutsche Bank AG 553,400 |
| State Street Bank & Trust Co. 62,800 |
| Nortrust Nominees 1,932,406 |
| Morgan Guaranty 284,600 |
| Barclays Bank 60,000 |
| Midland Bank plc 118,600 |
| Chase Nominees Limited 2,508,877 |
| Northern Trust 213,000 |
| Bank of New York Nominees 4,286,414 |
| State Street Nominees Limited 145,200 |
| Bank One London 103,200 |
| Citibank London 53,000 |
| Midland Bank plc 8,000 |
| Royal Bank of Scotland 67,100 |
| State Street Bank & Trust Co. 38,600 |
| Lloyds Bank 24,800 |
| Citibank NA 17,600 |
| Deutsche Bank AG 26,100 |
| Chase Nominees Limited 340,100 |
| Bank of New York Nominees 138,400 |
| HSBC Bank plc 24,200 |
| Chase Manhattan Nominee Ltd 5,300 |
| Citibank NA 98,400 |
| Citibank 10,000 |
| State Street Bank & Trust Co. 14,999 |
| Nortrust Nominees 93,500 |
| Chase Nominees Limited 755,600 |
| State Street Nominees Limited 548,500 |
| Citibank London 21,300 |
5. Number of shares / amount of stock acquired
| 2,789,288 (since last notification) |
6. Percentage of issued class
| 1.01% |
7. Number of shares / amount of stock disposed
| N/a |
8. Percentage of issued class
| N/a |
9. Class of security
| Ordinary 50p shares |
10. Date of transaction
| 10 January 2003 |
11. Date company informed
| 14 January 2003 |
12. Total holding following this notification
| 19,323,596 |
13. Total percentage holding of issued class following this notification
| 7.01% |
14. Any additional information
15. Name of contact and telephone number for queries
| Cheryl Cramer
01753 447933 |
16. Name and signature of authorised company official responsible for making
this notification
| Cheryl Cramer |
Date of notification
| 14 January 2003 |
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH GROUP PLC
(Registrant)
By: /s/ PETER ALLEN
Peter Allen
Chief Financial Officer
Dated: 14 January, 2003